BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25932953)

  • 1. Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents.
    Pasdar EA; Smits M; Stapelberg M; Bajzikova M; Stantic M; Goodwin J; Yan B; Stursa J; Kovarova J; Sachaphibulkij K; Bezawork-Geleta A; Sobol M; Filimonenko A; Tomasetti M; Zobalova R; Hozak P; Dong LF; Neuzil J
    PLoS One; 2015; 10(5):e0119549. PubMed ID: 25932953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner.
    Yan B; Stantic M; Zobalova R; Bezawork-Geleta A; Stapelberg M; Stursa J; Prokopova K; Dong L; Neuzil J
    BMC Cancer; 2015 May; 15():401. PubMed ID: 25967547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways.
    Ohno Y; Shingyoku S; Miyake S; Tanaka A; Fudesaka S; Shimizu Y; Yoshifuji A; Yamawaki Y; Yoshida S; Tanaka S; Sakura K; Tanaka T
    Oncogene; 2018 Dec; 37(49):6357-6367. PubMed ID: 30061637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells.
    Pattarozzi A; Carra E; Favoni RE; Würth R; Marubbi D; Filiberti RA; Mutti L; Florio T; Barbieri F; Daga A
    Stem Cell Res Ther; 2017 May; 8(1):119. PubMed ID: 28545562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells.
    Leccia F; Del Vecchio L; Mariotti E; Di Noto R; Morel AP; Puisieux A; Salvatore F; Ansieau S
    Mol Cancer; 2014 Sep; 13():213. PubMed ID: 25216750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and identification of chemotherapy-enriched sphere-forming cells from a patient with gastric cancer.
    Bagheri V; Memar B; Behzadi R; Aliakbarian M; Jangjoo A; Bahar MM; Talebi S; Gholamin M; Abbaszadegan MR
    J Cell Physiol; 2018 Oct; 233(10):7036-7046. PubMed ID: 29744869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem Cell Factor-Based Identification and Functional Properties of In Vitro-Selected Subpopulations of Malignant Mesothelioma Cells.
    Blum W; Pecze L; Felley-Bosco E; Wu L; de Perrot M; Schwaller B
    Stem Cell Reports; 2017 Apr; 8(4):1005-1017. PubMed ID: 28285878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spheres derived from the human SN12C renal cell carcinoma cell line are enriched in tumor initiating cells.
    Zhang Y; Sun B; Zhao X; Sun H; Cui W; Liu Z; Yao X; Dong X
    J Exp Clin Cancer Res; 2016 Oct; 35(1):163. PubMed ID: 27756344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy.
    Deng XB; Xiao L; Wu Y; Jin F; Mossman B; Testa JR; Xiao GH
    Int J Cancer; 2015 Jul; 137(2):481-90. PubMed ID: 25501304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells.
    Yamazaki H; Naito M; Ghani FI; Dang NH; Iwata S; Morimoto C
    Biochem Biophys Res Commun; 2012 Mar; 419(3):529-36. PubMed ID: 22369943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective AKT Inhibition by MK-2206 Represses Colorectal Cancer-Initiating Stem Cells.
    Malkomes P; Lunger I; Luetticke A; Oppermann E; Haetscher N; Serve H; Holzer K; Bechstein WO; Rieger MA
    Ann Surg Oncol; 2016 Sep; 23(9):2849-57. PubMed ID: 27059026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is sphere assay useful for the identification of cancer initiating cells of the ovary?
    Martínez-Serrano MJ; Caballero-Baños M; Vilella R; Vidal L; Pahisa J; Martínez-Roman S
    Int J Gynecol Cancer; 2015 Jan; 25(1):12-7. PubMed ID: 25365589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.
    Kim DK; Seo EJ; Choi EJ; Lee SI; Kwon YW; Jang IH; Kim SC; Kim KH; Suh DS; Seong-Jang K; Lee SC; Kim JH
    Exp Mol Med; 2016 Aug; 48(8):e255. PubMed ID: 27561949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
    Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
    Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD49f(high) cells retain sphere-forming and tumor-initiating activities in human gastric tumors.
    Fukamachi H; Seol HS; Shimada S; Funasaka C; Baba K; Kim JH; Park YS; Kim MJ; Kato K; Inokuchi M; Kawachi H; Yook JH; Eishi Y; Kojima K; Kim WH; Jang SJ; Yuasa Y
    PLoS One; 2013; 8(8):e72438. PubMed ID: 24015244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri.
    Feng D; Peng C; Li C; Zhou Y; Li M; Ling B; Wei H; Tian Z
    Oncol Rep; 2009 Nov; 22(5):1129-34. PubMed ID: 19787230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD24
    Zhou Z; Li Y; Kuang M; Wang X; Jia Q; Cao J; Hu J; Wu S; Wang Z; Xiao J
    EBioMedicine; 2020 Jan; 51():102598. PubMed ID: 31901872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells.
    Manente AG; Pinton G; Zonca S; Cilli M; Rinaldi M; Daga A; Nilsson S; Moro L
    Oncotarget; 2015 Sep; 6(28):25121-34. PubMed ID: 26208479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension.
    Bortolomai I; Canevari S; Facetti I; De Cecco L; Castellano G; Zacchetti A; Alison MR; Miotti S
    Cell Cycle; 2010 Mar; 9(6):1194-206. PubMed ID: 20237414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma.
    Sun X; Martin RCG; Zheng Q; Farmer R; Pandit H; Li X; Jacob K; Suo J; Li Y
    Cell Oncol (Dordr); 2018 Dec; 41(6):651-662. PubMed ID: 30116994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.